Document:

EX-10.15

 Exhibit 10.15 

June 27, 2019 
 Mr. Mikael Ottosson 

c/o Medallia, Inc. 
 575 Market Street, Suite 1850 

San Francisco, California 94105 
 Dear Mr. Ottosson: 

This letter agreement (the “Agreement”) is entered into between Mikael Ottosson (“you”) and Medallia, Inc. (the
“Company” or “we”), effective as of June 27, 2019 (the “Effective Date”), to confirm the terms and conditions of your employment with the Company as of the Effective Date. This Agreement
supersedes and replaces any and all employment terms, compensation, or benefits you may have had or to which you may have been entitled prior to the Effective Date. 

1. Title/Position. You will continue to serve as the Company’s Executive Vice President, Chief Technology Officer. You also
will continue to report to the Company’s Chief Executive Officer and will perform the duties and responsibilities customary for such position and such other related duties as are lawfully assigned by the Company’s Chief Executive Officer.
By signing this Agreement, you confirm that you continue to have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company. 

2. Base Salary. As of the Effective Date, your annual base salary is $400,000, which will be payable, less any applicable
withholdings, in accordance with the Company’s normal payroll practices. Your annual base salary will be subject to review and adjustment from time to time by our Board or its Compensation Committee (the “Committee”), as
applicable, in its sole discretion. 
 3. Annual Bonus. For the Company’s 2020 fiscal year, you will have the opportunity
to earn a target annual cash bonus equal to 60% of your annual base salary earned during the fiscal year, based on achieving performance objectives established by the Board or Committee, as applicable, in its sole discretion and payable upon
achievement of those objectives as determined by the Committee. Unless determined otherwise by the Board or Committee, as applicable, any such bonus will be subject to your continued employment through and until the date of payment. Your annual
bonus opportunity and the applicable terms and conditions may be adjusted from time to time by our Board or the Committee, as applicable, in its sole discretion. 

4. Equity Awards. You will be eligible to receive awards of stock options, restricted stock units or other equity awards pursuant
to any plans or arrangements the Company may have in effect from time to time. The Board or Committee, as applicable, will determine in its sole discretion whether you will be granted any such equity awards and the terms of any such award in
accordance with the terms of any applicable plan or arrangement that may be in effect from time to time. Your equity awards outstanding as of the Effective Date will continue in effect on their existing terms. 

5. Employee Benefits. You will continue to be eligible to participate in the benefit plans and programs established by the
Company for its employees from time to time, subject to their applicable terms and conditions, including without limitation any eligibility requirements. The Company reserves the right to modify, amend, suspend or terminate the benefit plans and
programs it offers to its employees at any time. 

 6. Severance. As of the Effective Date, you will be eligible to enter into
participate in the Company’s Change in Control and Severance Policy (the “CIC/Severance Policy”) with the benefits applicable to you based on your position within the Company. The CIC/Severance Policy and the participation
agreement under the CIC/Severance Policy that you signed at the same time as this letter specify the severance payments and benefits you may become entitled to receive in connection with certain qualifying terminations of your employment with the
Company. These protections supersede all other severance payments and benefits to which you otherwise may be entitled, or may become entitled in the future, under any plan, program or policy that the Company may have in effect from time to time. For
purposes of clarification, any severance benefits or arrangements that may have applied to you before the Effective Date no longer will apply and you will have no rights or entitlements under any such plans, programs, agreements or arrangements.

 7. Confidentiality Agreement. As an employee of the Company, you will continue to have access to certain confidential
information of the Company and you may, during the course of your employment, develop certain information or inventions that will be the property of the Company. To protect the interests of the Company, your acceptance of this Agreement confirms
that the terms of the Company’s Employee Proprietary Information and Inventions Agreement you previously signed with the Company (the “Confidentiality Agreement”) still apply. 

8. Arbitration. To ensure the rapid and economical resolution of disputes that may arise in connection with your employment with
the Company, you and the Company agree that any and all disputes, claims or causes of action, in law or equity, arising from or relating to the enforcement, breach, performance, or interpretation of this Agreement, your employment, or the
termination of your employment, shall be resolved, to the fullest extent permitted by law, by final, binding and confidential arbitration in San Francisco, California conducted by Judicial Arbitration and Mediation Services, Inc.
(“JAMS”) or its successor, under the then applicable rules of JAMS. You acknowledge that by agreeing to this arbitration procedure, both you and the Company waive the right to resolve any such dispute through a trial by jury or
judge or administrative proceeding. The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written
arbitration decision including the arbitrator’s essential findings and conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that you or the Company would be entitled to seek in a court of
law. The Company shall pay all JAMS’ arbitration fees in excess of those which would be required if the dispute were decided in a court of law. Nothing in this Agreement is intended to prevent either you or the Company from obtaining injunctive
relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Notwithstanding the foregoing, you and the Company each have the right to resolve any issue or dispute arising under the Confidentiality Agreement by court
action instead of arbitration. 
 9. At-Will Employment. This Agreement does not imply
any right to your continued employment for any period with the Company or any of its affiliates. Your employment with the Company will continue to be “at will.” It is for no specified term, and may be terminated by you or the Company at
any time, with or without cause or advance notice. 
 10. Protected Activity Not Prohibited. Nothing in this Agreement or in
any other agreement between you and the Company, as applicable, will in any way limit or prohibit you from engaging for a lawful purpose in any Protected Activity. For purposes of this Agreement, “Protected Activity” means filing a
charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or proceeding that may be conducted by, any state, federal, or local governmental 

  
 2 

 
agency or commission, including the U.S. Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor
Relations Board (the “Government Agencies”). You understand that in connection with such Protected Activity, you are permitted to disclose documents or other information as permitted by law, and without giving notice to, or
receiving authorization from, the Company. Notwithstanding the foregoing, you agree to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute Company confidential information under the
Confidentiality Agreement to any parties other than the Government Agencies. You further understand that “Protected Activity” does not include the disclosure of any Company attorney-client privileged communications. Any language in the
Confidentiality Agreement regarding your right to engage in Protected Activity that conflicts with, or is contrary to, this paragraph is superseded by this Agreement. In addition, pursuant to the Defend Trade Secrets Act of 2016, you are notified
that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or
indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under
seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court
proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order. 

11. Miscellaneous. This Agreement, together with the Confidentiality Agreement, the CIC/Severance Policy and any outstanding
equity awards granted to you by the Company under its 2017 Equity Incentive Plan and the applicable award agreements thereunder, constitute the entire agreement between you and the Company regarding the material terms and conditions of your
employment, and they supersede and replace all prior negotiations, representations or agreements between you and the Company. This Agreement may be modified only by a written agreement signed by you and a duly authorized officer of the Company. 

[Signature page follows.] 

  
 3 

 To confirm the current terms and conditions of your employment, please sign and date in the spaces indicated
and return this Agreement to me. 
  

	
	Sincerely,
	
	MEDALLIA, INC.
	
	 /s/ Leslie Stretch

	Leslie Stretch
	
	CEO
	
	ACCEPTED AND AGREED:
	
	 /s/ Mikael Ottosson

	Mikael Ottosson
	
	 7/1/2019

	Date

  
 4Exhibit 4.1

    

     

    

    
      	
              NUMBER

            	
              UNITS

            

       

      

      U-

       

      

      SEE REVERSE FOR CERTAIN DEFINITIONS

      CUSIP [●]

       

      

      SC HEALTH CORPORATION

      

      

      UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE-HALF OF ONE WARRANT,

      EACH WHOLE WARRANT ENTITLING THE HOLDER TO PURCHASE ONE CLASS A ORDINARY SHARE

      

      

      THIS CERTIFIES THAT           is the
          owner of Units of SC Health Corporation, a Cayman Islands exempted company (the “Company”), transferrable on the books of
          the Company in person or by duly authorized attorney upon surrender of this certificate properly endorsed.

      

      

      Each Unit (“Unit”)
        consists of one (1) Class A ordinary share, par value $0.0001 per share (“Ordinary Share”), of the Company and one-half (1/2)
        of one redeemable warrant (the “Warrant”). Each whole Warrant entitles the holder to purchase one Ordinary Share (subject to
        adjustment) for $11.50 per share (subject to adjustment). Each Warrant will become exercisable on the later of (i) thirty (30) days after the Company’s completion of a merger, share exchange, asset acquisition, share purchase, reorganization or
        other similar business combination with one or more businesses (each a “Business Combination”), or (ii) twelve (12) months
        from the closing of the Company’s initial public offering, and will expire unless exercised before 5:00 p.m., New York City Time, on the date that is five (5) years after the date on which the Company completes its initial Business Combination, or
        earlier upon redemption or liquidation (the “Expiration Date”). The Ordinary Shares and Warrants comprising the Units
        represented by this certificate are not transferable separately prior to         , 2019, unless Credit Suisse Securities (USA) LLC elects to allow separate trading earlier, subject to the Company’s filing of a Current Report on Form 8-K with the
        Securities and Exchange Commission containing an audited balance sheet reflecting the Company’s receipt of the gross proceeds of the Company’s initial public offering and issuing a press release announcing when separate trading will begin. No
        fractional Warrants will be issued upon separation of the Units. The terms of the Warrants are governed by a Warrant Agreement, dated as of          , 2019, between the Company and American Stock Transfer & Trust Company, LLC, as Warrant Agent,
        and are subject to the terms and provisions contained therein, all of which terms and provisions the holder of this certificate consents to by acceptance hereof. Copies of the Warrant Agreement are on file at the office of the Warrant Agent at 6201
        15th Avenue, Brooklyn, New York 11219, and are available to any Warrant holder on written request and without cost.

      

      

      This certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar of the Company.

      

      

      This certificate shall be governed by and construed in accordance with the internal laws of the State of New York.

      

      

      Witness the facsimile signature of a duly authorized signatory of the Company.

       

      

      	 	 	 
	 	
              Authorized Signatory

            	 

       

      	 	 	 
	 	
              Transfer Agent

            	 

      
        
          

      

      SC Health Corporation

      

      

      The Company will furnish without charge to each unitholder who so requests, a statement of the powers, designations, preferences and
        relative, participating, optional or other special rights of each class of equity or series thereof of the Company and the qualifications, limitations, or restrictions of such preferences and/or rights.

      

      

      The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were
        written out in full according to applicable laws or regulations:

      

      

      	
              TEN COM

            	
              —

            	
              as tenants in common

            	 	
              UNIF GIFT MIN ACT

            	
              —

            	
              ___________ Custodian ___________

            
	 	 	 	 	 	 	
              (Cust) (Minor)

            
	
              TEN ENT

            	
              —

            	
              as tenants by the entireties

            	 	 	 	 
	 	 	 	 	 	 	
              Under Uniform Gifts to Minors Act

            
	
              JT TEN

            	
              —

            	
              as joint tenants with right of survivorship and not as tenants in common

            	 	 	 	
              _____________________________

              (State)

            

      

      

      Additional abbreviations may also be used though not in the above list.

      

      

      For value received, hereby sell, assign and transfer unto

      

      

      (PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE)

      

      

      (PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)

      

      

      Units represented by the within certificate, and do hereby irrevocably constitute and appoint

      Attorney to transfer the said Units on the books of the within named Company with full power of substitution in the
        premises.

      

      

      Dated

      	 	 	 
	 	
              Notice:

            	
              The signature to this assignment must correspond with the name as written upon the face of the certificate in every particular, without
                alteration or enlargement or any change whatever.

            
	
              Signature(s) Guaranteed:

            	 	 	 	 
	 	 	 	 	 	 
	
              THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS
                WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (OR ANY SUCCESSOR RULE)).

            	 	 	 	 	 
	 	 	 	 	 

      
        
          

      

      As more fully described in, and subject to the terms and conditions described in, the Company’s final prospectus for its initial
        public offering dated , the holder(s) of this certificate shall be entitled to receive a pro-rata portion of certain funds held in the trust account established in connection with the Company’s initial public offering in the event that (i) the
        Company redeems the Class A Ordinary Shares sold in its initial public offering and liquidates because it does not consummate an initial business combination within the time period set forth in the Company’s Amended and Restated Memorandum and
        Articles of Association, as the same may be amended from time to time, subject to applicable law or (ii) if the holder(s) properly redeem for cash his, her or its respective Class A Ordinary Shares included in the Units represented by this
        certificate in connection with (x) a tender offer (or proxy solicitation, solely in the event the Company seeks shareholder approval of the proposed initial business combination) setting forth the details of a proposed initial business combination
        or (y) a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association (1) to modify the substance or timing of the Company’s obligation to redeem 100% of the Class A Ordinary Shares if it does not consummate
        an initial business combination within the time set forth in the Company’s Amended and Restated Memorandum and Articles of Association, as the same may be amended from time to time, or (2) with respect to any other provisions relating to the rights
        of the Company’s Class A Ordinary Shares. In no other circumstances shall the holder(s) have any right or interest of any kind in or to the trust account.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}]]